Fig 1.
Enrolment, screening and follow up.
Table 1.
Socio-demographic characteristics of HIV-infected patients with 20 and above years of age on ART follow up care at Zewditu Memorial Hospital, Addis Ababa, Ethiopia.
Table 2.
The risk for atherosclerosis cardiovascular disease using the Pooled Cohort Equation and the Framingham Risk Score in HIV-infected patients aged 40 to 79 years at Zewditu Memorial Hospital, Addis Ababa, Ethiopia.
Table 3.
Association between ASCVD risk using FRS and clinical characteristics among people living with HIV/AIDS at Zewditu Memorial Hospital, Addis Ababa, Ethiopia.
Table 4.
Association between ASCVD risk using FRS and clinical characteristics among people living with HIV/AIDS age 40 75 years at Zewditu Memorial Hospital, Addis Ababa, Ethiopia.
Table 5.
Association between ASCVD risk using PCE and clinical characteristics among people living with HIV/AIDS age 40 to 75 years at Zewditu Memorial Hospital, Addis Ababa, Ethiopia.
Fig 2.
The ASCVD risk based on ART regimen and age interaction among PLWHA age 40–79 years: using the pooled cohort equation (a), and the Framingham risk score (b) estimation.
Fig 3.
The ASCVD risk based on ART regimen and gender interaction among PLWHA age 40–79 years: using the pooled cohort equation (a), and the Framingham risk score (b) estimation.
Fig 4.
The ASCVD risk based on ART regimen and blood type interaction among PLWHA age 40–79 years: using the pooled cohort equation (a), and the Framingham risk score (b) estimation.